These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1669481)
1. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X). Viana MB; Oliveira BM; Silva CM; Rios Leite VH Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Langerhans cell histiocytosis in children with etoposide. Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115 [TBL] [Abstract][Full Text] [Related]
3. Etoposide in Langerhans cell histiocytosis in children: a preliminary experience. Basade MM; Nair CN; Kurkure PA; Pai SK; Advani SH Pediatr Hematol Oncol; 1996; 13(2):159-62. PubMed ID: 8721030 [TBL] [Abstract][Full Text] [Related]
4. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X). Broadbent V; Pritchard J; Yeomans E Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842 [TBL] [Abstract][Full Text] [Related]
6. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society. Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031 [TBL] [Abstract][Full Text] [Related]
7. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation]. Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704 [TBL] [Abstract][Full Text] [Related]
8. Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative study. Ceci A; de Terlizzi M; Colella R; Balducci D; Toma MG; Zurlo MG; Macchia P; Mancini A; Indolfi P; Locurto M Cancer; 1988 Dec; 62(12):2528-31. PubMed ID: 3056605 [TBL] [Abstract][Full Text] [Related]
9. Excellent remission rates with limited toxicity in relapsed/refractory Langerhans cell histiocytosis with pulse dexamethasone and lenalidomide in children. Uppuluri R; Ramachandrakurup S; Subburaj D; Bakane A; Raj R Pediatr Blood Cancer; 2017 Jan; 64(1):110-112. PubMed ID: 27555565 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide. Yu LC; Shenoy S; Ward K; Warrier RP Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350 [TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis. Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090 [TBL] [Abstract][Full Text] [Related]
12. [Treatment results of Langerhans cell histiocytosis with LSH II protocol]. Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India. Narula G; Pradhan ND; Arora B; Banavali SD Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864 [TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489 [TBL] [Abstract][Full Text] [Related]
15. Treatment of adult Langerhans cell histiocytosis with etoposide. Tsele E; Thomas DM; Chu AC J Am Acad Dermatol; 1992 Jul; 27(1):61-4. PubMed ID: 1619078 [TBL] [Abstract][Full Text] [Related]
16. Re: "Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)" by Viana et al. Whitlock JA Med Pediatr Oncol; 1993; 21(5):379. PubMed ID: 8492755 [No Abstract] [Full Text] [Related]
17. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC. Culić S; Jakobson A; Culić V; Kuzmić I; Sćukanec-Spoljar M; Primorac D Pediatr Hematol Oncol; 2001 Jun; 18(4):291-4. PubMed ID: 11400655 [TBL] [Abstract][Full Text] [Related]
18. Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy. Miura T; Nakamura M; Tsunematsu Y; Fujimoto J; Meguro T; Yamada K Acta Paediatr Jpn; 1993 Apr; 35(2):148-50. PubMed ID: 8503273 [TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposide and prednisone. Körholz D; Janssen G; Göbel U Pediatr Hematol Oncol; 1997; 14(5):443-9. PubMed ID: 9267876 [TBL] [Abstract][Full Text] [Related]